Home Hatchtech inks $279m head lice deal as VC market comes to life
 

Keywords :   


Hatchtech inks $279m head lice deal as VC market comes to life

2015-09-13 13:56:17| Biotech - Topix.net

Australian pharmaceutical company Hatchtech has inked a deal worth up to $279 million with Indian giant Dr. Reddy's for the commercialisation of its innovative head lice treatment. Dr Reddy's Laboratories, a $US10.3 billion integrated pharmaceutical group listed in New York, will pay Hatchtech an undisclosed upfront fee, up to $85 million in pre-commercialisation milestone payments, and the remainder of the $279 million subject to sales-based milestones.

Tags: to life market head

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »